title: Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction.
abstract: BACKGROUND
  Several cases of hypotension have been reported in patients who received angiotensin-converting enzyme inhibitors (ACEIs) before a surgical procedure, suggesting that interactions between ACEIs and anesthesia may be neither beneficial nor predictable. To determine if continuation of ACEI therapy until the morning of surgery leads to an unacceptable decrease in blood pressure on induction, we investigated 51 vascular surgical patients that were chronically treated for hypertension with either captopril or enalapril.
  
  
  METHODS
  After randomization, ACEI therapy was either continued until the morning of surgery or stopped at the time of the preanesthetic visit, at least 12 h (captopril) or 24 h (enalapril) before surgery. Each patient received a standardized anesthetic induction. If systolic blood pressure (monitored using a radial artery cannula) decreased to less than 90 mmHg in response to induction, ephedrine was administered.
  
  
  RESULTS
  A marked decrease in plasma converting-enzyme activity was found in patients who received enalapril until the morning of the surgical procedure, and 100% of them required ephedrine after induction. In patients who received their usual dose of captopril on the morning of surgery, plasma converting-enzyme activity was reduced to a lesser extent (when compared with patients who received enalapril). Finally, in the patients in whom ACEI therapy, either enalapril or captopril, was stopped of the evening before surgery, the incidence of induction-induced hypotension was significantly less when enalapril or captopril therapy has been discontinued.
  
  
  CONCLUSIONS
  These data indicate that in hypertensive patients chronically treated with ACEIs, maintenance of therapy until the day of surgery may increase the probability of hypotension at induction.
authors.affiliation: Department of Anesthesiology and Intensive Care, Hôpital de la Pitié-Salpétrière, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Coriat
authors.forename: C
authors.initials: C
authors.lastname: Richer
authors.forename: T
authors.initials: T
authors.lastname: Douraki
authors.forename: C
authors.initials: C
authors.lastname: Gomez
authors.forename: K
authors.initials: K
authors.lastname: Hendricks
authors.forename: J F
authors.initials: JF
authors.lastname: Giudicelli
authors.forename: P
authors.initials: P
authors.lastname: Viars
mesh_terms: D000758:Anesthesia; D000777:Anesthetics / Q000627:therapeutic use*; D002216:Captopril / Q000009:adverse effects* / Q000097:blood; D004336:Drug Antagonism; D016903:Drug Monitoring; D004656:Enalapril / Q000009:adverse effects* / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced*; D008297:Male
chemical_list: D000777:Anesthetics; D004656:Enalapril; D002216:Captopril